Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dr.Reddy's Laboratories Ltd Launches Pamorelin LA in India-Business Standard


Friday, 7 Dec 2012 05:57am EST 

Business Standard reported that Dr.Reddy's Laboratories Ltd has launched Pamorelin LA in India on December 3, 2012 under an exclusive marketing and sales agreement with Switzerland-based Debiopharm Group, a global biopharmaceutical group with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics. 

Company Quote

3049.95
40.85 +1.36%
3:29am EDT